> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Innoveix Pharma Recall of Sterile Products
- URL: https://www.fdaweb.com/innoveix-pharma-recall-of-sterile-products/
- Published: 2021-07-14T12:00:00.000Z
- Updated: 2026-09-14T17:06:07.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5149712

Innoveix Pharmaceuticals has recalled several lots of sterile compounded drug products due to a lack of sterility assurance that was determined by a recent FDA inspection. “Administration of a drug product intended to be sterile, that is not sterile, could result in serious infections which may be life-threatening,” a recall notice says. To date, the company says it has not received any reports of adverse events related to the recall. Affected products include injectable semorelin/pamorelin,3mg, and injectable AOD-9604, 3mg. The products can be identified by an Innoveix Pharmaceuticals label, the notice says.